Aztreonam

Product NDC: 63323-401
Requested package NDC: 63323-401-26
11-digit product format: 633230401
Labeler code: 63323
Product ID: 63323-401_6cd42e51-1a5d-4c6a-8881-0cbde3ca8d70
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: AZTREONAM
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAMUSCULAR; INTRAVENOUS
Labeler: Fresenius Kabi USA, LLC
Application: ANDA065439
Marketing category: ANDA
Marketing start: 2009-11-05
Substance: AZTREONAM
Active strength: 1 g/1
Pharmacologic classes: Monobactam Antibacterial [EPC], Monobactams [CS]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A065439-001	AZTREONAM	AZTREONAM	500MG/VIAL	INJECTABLE / INJECTION		2010-06-18
A065439-002	AZTREONAM	AZTREONAM	1GM/VIAL	INJECTABLE / INJECTION	AP	2010-06-18
A065439-003	AZTREONAM	AZTREONAM	2GM/VIAL	INJECTABLE / INJECTION	AP	2010-06-18

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A065439-002	AP
A065439-003	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 129 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A065439-001	AZTREONAM	500MG/VIAL	INJECTABLE / INJECTION		2010-06-18	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A065439-002	AZTREONAM	1GM/VIAL	INJECTABLE / INJECTION	AP	2010-06-18	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A065439-003	AZTREONAM	2GM/VIAL	INJECTABLE / INJECTION	AP	2010-06-18	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A065439-001	AZTREONAM	500MG/VIAL	INJECTABLE / INJECTION		2010-06-18	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065439-002	AZTREONAM	1GM/VIAL	INJECTABLE / INJECTION	AP	2010-06-18	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065439-003	AZTREONAM	2GM/VIAL	INJECTABLE / INJECTION	AP	2010-06-18	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A065439-001	AZTREONAM	500MG/VIAL	INJECTABLE / INJECTION		2010-06-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065439-002	AZTREONAM	1GM/VIAL	INJECTABLE / INJECTION	AP	2010-06-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065439-003	AZTREONAM	2GM/VIAL	INJECTABLE / INJECTION	AP	2010-06-18	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065439-001	AZTREONAM	500MG/VIAL	INJECTABLE / INJECTION		2010-06-18	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065439-002	AZTREONAM	1GM/VIAL	INJECTABLE / INJECTION	AP	2010-06-18	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065439-003	AZTREONAM	2GM/VIAL	INJECTABLE / INJECTION	AP	2010-06-18	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065439-001	AZTREONAM	500MG/VIAL	INJECTABLE / INJECTION		2010-06-18	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065439-002	AZTREONAM	1GM/VIAL	INJECTABLE / INJECTION	AP	2010-06-18	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065439-003	AZTREONAM	2GM/VIAL	INJECTABLE / INJECTION	AP	2010-06-18	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065439-001	AZTREONAM	500MG/VIAL	INJECTABLE / INJECTION		2010-06-18	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065439-002	AZTREONAM	1GM/VIAL	INJECTABLE / INJECTION	AP	2010-06-18	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065439-003	AZTREONAM	2GM/VIAL	INJECTABLE / INJECTION	AP	2010-06-18	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065439-001	AZTREONAM	500MG/VIAL	INJECTABLE / INJECTION		2010-06-18	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065439-002	AZTREONAM	1GM/VIAL	INJECTABLE / INJECTION	AP	2010-06-18	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065439-003	AZTREONAM	2GM/VIAL	INJECTABLE / INJECTION	AP	2010-06-18	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065439-001	AZTREONAM	500MG/VIAL	INJECTABLE / INJECTION		2010-06-18	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065439-002	AZTREONAM	1GM/VIAL	INJECTABLE / INJECTION	AP	2010-06-18	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065439-003	AZTREONAM	2GM/VIAL	INJECTABLE / INJECTION	AP	2010-06-18	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065439-001	AZTREONAM	500MG/VIAL	INJECTABLE / INJECTION		2010-06-18	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065439-002	AZTREONAM	1GM/VIAL	INJECTABLE / INJECTION	AP	2010-06-18	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065439-003	AZTREONAM	2GM/VIAL	INJECTABLE / INJECTION	AP	2010-06-18	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065439-001	AZTREONAM	500MG/VIAL	INJECTABLE / INJECTION		2010-06-18	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065439-002	AZTREONAM	1GM/VIAL	INJECTABLE / INJECTION	AP	2010-06-18	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065439-003	AZTREONAM	2GM/VIAL	INJECTABLE / INJECTION	AP	2010-06-18	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065439-001	AZTREONAM	500MG/VIAL	INJECTABLE / INJECTION		2010-06-18	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065439-002	AZTREONAM	1GM/VIAL	INJECTABLE / INJECTION	AP	2010-06-18	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065439-003	AZTREONAM	2GM/VIAL	INJECTABLE / INJECTION	AP	2010-06-18	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065439-001	AZTREONAM	500MG/VIAL	INJECTABLE / INJECTION		2010-06-18	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065439-002	AZTREONAM	1GM/VIAL	INJECTABLE / INJECTION	AP	2010-06-18	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065439-003	AZTREONAM	2GM/VIAL	INJECTABLE / INJECTION	AP	2010-06-18	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065439-001	AZTREONAM	500MG/VIAL	INJECTABLE / INJECTION		2010-06-18	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065439-002	AZTREONAM	1GM/VIAL	INJECTABLE / INJECTION	AP	2010-06-18	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065439-003	AZTREONAM	2GM/VIAL	INJECTABLE / INJECTION	AP	2010-06-18	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065439-001	AZTREONAM	500MG/VIAL	INJECTABLE / INJECTION		2010-06-18	`301d65b070ca…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	A065439-002	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A065439-003	AP	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A065439-002	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065439-003	AP	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A065439-002	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065439-003	AP	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065439-002	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065439-003	AP	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065439-002	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065439-003	AP	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065439-002	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065439-003	AP	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065439-002	AP	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065439-003	AP	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065439-002	AP	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065439-003	AP	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065439-002	AP	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065439-003	AP	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065439-002	AP	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065439-003	AP	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065439-002	AP	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065439-003	AP	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065439-002	AP	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065439-003	AP	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065439-002	AP	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065439-003	AP	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065439-002	AP	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065439-003	AP	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065439-002	AP	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065439-003	AP	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065439-002	AP	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A065439-003	AP	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065439-002	AP	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065439-003	AP	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065439-002	AP	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A065439-003	AP	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065439-002	AP	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A065439-003	AP	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065439-002	AP	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A065439-003	AP	1	`74a2ff9319b5…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Aztreonam
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
AZTREONAM	1 g/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
G2B4VE5GH8	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1664981	Internal RxNorm lookup
1664986	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
302fd27d-0a22-44ea-91fb-1b1ffcf17a1f	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
458b18b0-b105-44ac-b090-378873a4e07b	Product name	1	20251118
882349af-ee4e-3057-6dd7-68d0b142db19	Product name	2	20220608
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
1681bc73-b05f-12c3-1075-382ae39f449c	Product name	1	20140508
74c5690d-3e83-e116-f1e7-47b67331bf80	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
63323-401-01	Aztreonam	1 in 1 VIAL	INJECTION, POWDER, LYOPHILIZED,	1	9
63323-401-20	Aztreonam	10 in 1 TRAY	INJECTION, POWDER, LYOPHILIZED,	10	9
63323-401-24	Aztreonam	10 in 1 TRAY	INJECTION, POWDER, LYOPHILIZED,	10	6
63323-401-41	Aztreonam	1 in 1 VIAL	INJECTION, POWDER, LYOPHILIZED,	1	6
63323-401-21	Aztreonam	1 in 1 VIAL	INJECTION, POWDER, LYOPHILIZED,	1	4
63323-401-26	Aztreonam	10 in 1 TRAY	INJECTION, POWDER, LYOPHILIZED,	10	4

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
63323-401-01	EA - Each	63323-401	a9386f71-2a19-4f1b-a550-feee3dea5522	1	2022-04-06
63323-401-20	EA - Each	63323-401	a71b0183-505c-41a9-ac62-0fee3e4ac51e	1	2012-07-24
63323-401-21	EA - Each	63323-401	cba85672-d36e-4f89-b42c-bb91916b5931	1	2023-04-07
63323-401-24	EA - Each	63323-401	42869732-d570-49f8-9692-dcc2e4ed5628	1	2014-09-03
63323-401-26	EA - Each	63323-401	e2b013d2-0070-4bbf-ba9f-90f82821001e	1	2015-06-09
63323-401-41	EA - Each	63323-401	41e4c816-e06b-4051-a14c-9d1ca83e353d	1	2022-07-06

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
AZTREONAM	ACTIVE INGREDIENT	G2B4VE5GH8	AZTREONAM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC]	4
AZTREONAM	ACTIVE MOIETY	G2B4VE5GH8	AZTREONAM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC]	4
ARGININE	INACTIVE INGREDIENT	94ZLA3W45F	AZTREONAM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC]	4
AZTREONAM	ACTIVE INGREDIENT	G2B4VE5GH8	AZTREONAM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC]	2
AZTREONAM	ACTIVE MOIETY	G2B4VE5GH8	AZTREONAM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC]	2
ARGININE	INACTIVE INGREDIENT	94ZLA3W45F	AZTREONAM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC]	2
AZTREONAM	ACTIVE INGREDIENT	G2B4VE5GH8	AZTREONAM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC]	1
AZTREONAM	ACTIVE MOIETY	G2B4VE5GH8	AZTREONAM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC]	1
ARGININE	INACTIVE INGREDIENT	94ZLA3W45F	AZTREONAM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
63323-401	AZTREONAM (AZTREONAM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC ]	9	Current NDC, Legacy NDC, 2 package rows	20220412_c6cf7e13-a04e-47e2-9cec-44a278ee6bec.zip
63323-401	AZTREONAM (AZTREONAM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC ]	6	Current NDC, Legacy NDC, 2 package rows	20220604_5f5ebb63-6ac5-4fb4-bcc1-d069c123eb18.zip
63323-401	AZTREONAM (AZTREONAM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC ]	4	Current NDC, Legacy NDC, 2 package rows	20220602_302fd27d-0a22-44ea-91fb-1b1ffcf17a1f.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Aztreonam	AZTREONAM	Fresenius Kabi USA, LLC	5f5ebb63-6ac5-4fb4-bcc1-d069c123eb18	2022-05-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065439 application number: ANDA065439 ndc (product): 63323-401
Aztreonam	AZTREONAM	Fresenius Kabi USA, LLC	302fd27d-0a22-44ea-91fb-1b1ffcf17a1f	2022-04-30	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065439 application number: ANDA065439 ndc (package): 63323-401-26 ndc (product): 63323-401 ndc11 (package): 63323040126
Aztreonam	AZTREONAM	Fresenius Kabi USA, LLC	c6cf7e13-a04e-47e2-9cec-44a278ee6bec	2022-03-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065439 application number: ANDA065439 ndc (product): 63323-401

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
G2B4VE5GH8	AZTREONAM	78110-38-0	AZTREONAM

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1664981	aztreonam 1 GM Injection	PSN	c6cf7e13-a04e-47e2-9cec-44a278ee6bec	9
1664986	aztreonam 2 GM Injection	PSN	c6cf7e13-a04e-47e2-9cec-44a278ee6bec	9
1664981	aztreonam 1000 MG Injection	SCD	c6cf7e13-a04e-47e2-9cec-44a278ee6bec	9
1664986	aztreonam 2000 MG Injection	SCD	c6cf7e13-a04e-47e2-9cec-44a278ee6bec	9
1664981	aztreonam 1 GM Injection	PSN	5f5ebb63-6ac5-4fb4-bcc1-d069c123eb18	6
1664986	aztreonam 2 GM Injection	PSN	5f5ebb63-6ac5-4fb4-bcc1-d069c123eb18	6
1664981	aztreonam 1000 MG Injection	SCD	5f5ebb63-6ac5-4fb4-bcc1-d069c123eb18	6
1664986	aztreonam 2000 MG Injection	SCD	5f5ebb63-6ac5-4fb4-bcc1-d069c123eb18	6
1664981	aztreonam 1 GM Injection	PSN	302fd27d-0a22-44ea-91fb-1b1ffcf17a1f	4
1664986	aztreonam 2 GM Injection	PSN	302fd27d-0a22-44ea-91fb-1b1ffcf17a1f	4
1664981	aztreonam 1000 MG Injection	SCD	302fd27d-0a22-44ea-91fb-1b1ffcf17a1f	4
1664986	aztreonam 2000 MG Injection	SCD	302fd27d-0a22-44ea-91fb-1b1ffcf17a1f	4

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
63323-401-26	63323040126	10 VIAL in 1 TRAY (63323-401-26) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (63323-401-21)	10 vial	2009-11-05	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Aztreonam - Fresenius Kabi USA, LLC	Fresenius Kabi USA, LLC	2022-05-06	HUMAN PRESCRIPTION DRUG LABEL	6
Aztreonam - Fresenius Kabi USA, LLC	Fresenius Kabi USA, LLC	2022-04-30	HUMAN PRESCRIPTION DRUG LABEL	4
Aztreonam FOR INJECTION, USP	Fresenius Kabi USA, LLC	2022-03-29	HUMAN PRESCRIPTION DRUG LABEL	9